chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bicep muscle twitch in left arm the day after vaccination.  Twitching occurs every hour of the day
This spontaneous report as received from a licensed practical nurse refers to a 19-year-old patient of an unknown gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown dates, the 19-year-old patient was vaccinated with two doses of VAQTA 0.5 ml, intramuscularly, lot# L004439, expiration date: 15-FEB-2016 and L034381, expiration date: 21-DEC-2016. There were no adverse effects reported. Additional information has been requested.
12 days after receiving booster she woke up with very large hives.  The hives would come and go and travel to different places on her body.  She doesn't have allergies and was not exposed to any new foods or products.  She was seen by her Dr..  They had us give her Benedryl and a topical cream and Famotidine 40mg5ml suspension 50ml daily and Levocetirizine 2.5 mg/5ml oral 10ml once a day.  That didn't work so they then gave her a stronger steroid Z-pac and Benadryl daily.  The Benadryl seems to make it disappear for awhile but it always returns.  This has been going on for about 3 weeks now.  I have taken pictures each day.  It is itchy and she gets very large raised areas.  She also gets small hives as well.  It has bounced around all different parts of her body, including her face.  I can appear in multiple places at once.  If we stop the Benedryl it is much worse.
Patient was transported to the hospital with c/o pain in her leg(s) and diagnosed with a DVT.
On 2/27/22 patient had 2 vaccines administered (Shingrix & Pneumovax 23) and today (3/3/22) came in with a red rash at the injection sites and reported it was hot and itchy.   She stated it started shortly after she received the vaccines.  She did say the itch and hot had cleared up though and it was doing better.  She is going to show her doctor tomorrow.   Rph also recommended over the counter treatment.
Information has been received from a physician (Local reference # CZE11/071) concerning a female patient who on an unspecified dates was vaccinated with a first and a second dose of GARDASIL (Route and Lot# not reported). The physician stated that on unspecified date the patient experienced fever (40 degrees C). The physician also stated that she did not administer the third dose. At the time of the report the patient's outcome was unknown. It was unknown if the patient sought medical attention. No further information is available.
Sweats; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweats), CHILLS (Chills) and PYREXIA (Fever) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Relapsing multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.    On 15-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Aug-2021, the patient experienced HYPERHIDROSIS (Sweats), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, HYPERHIDROSIS (Sweats), CHILLS (Chills) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not reported.
first shot 5 years ago, never got second; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose 5 years ago from reporting).   On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 08-AUG-2022 Reporter's comment: This case was received from patient via interactive digital media. The patient never got second Shingles shot. The reporter wanted to know can patient get second dose now. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingles vaccine, which led to incomplete course of vaccination. The follow-up could not be possible as no contact details were available.
Patient given pediatric Covid vaccine instead of adult dose. No symptoms. Patient notified. Pfizer and CDC contacted. Instructed that the patient can get correct dose at any time.
Received a menveo vaccine that was reconstituted incorrectly; Received a menveo vaccine that was reconstituted incorrectly; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 30th March 2021, the patient received Menveo. On 30th March 2021, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the dose of menveo and experienced received a menveo vaccine that was reconstituted incorrectly, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter inquired how to move forward with vaccination. The reporter consented to follow up.
Red Itchy Patch at vaccination site. Began 3/12/21 "Moderna Arm"?
Approximately 12 hours after injection, I woke (about 2:00am, 04/07/2021) with body aches, fever (100°F or higher) and chills, headache, and soreness in my left arm. These symptoms continued until about 2:00pm 04/08/2021 when they rapidly subsided. I did occasionally take acetaminophen to help reduce the fever.   04/08/2021 not sure of this is related or coincidental, but I had irritation on the skin of my penis after having intercourse with my girlfriend. I did receive a yeast infection after my first dose, and I've never had either of these issues before or since.
This child was in on 02/14/01 at 4:05 PM with complaints of a rash; she had vaccinations this AM, 02/14/01. The rash was noted at the right wrist, underneath both eyes, behind her right ear and left and right thighs. The left thigh worse than the right, rash red and raised , small hive cluster together. The child c/o of itching, no swelling, difficulty swallowing, or breathing. The grandmother instructed to use Benadryl and Hydrocortisone cream to rash areas, keep the child cool and bathe in oatmeal bath. If any swelling, difficulty breathing or swallowing noted take her to the ER or call 911.
Temperature of 99 and rash noted on body morning after vaccine. Mother called health department Monday morning with complaint of fever gone but rash continued to spread over child's entire body. Did not appear to bother child as far as itching.
Hello I read the reaction on CDC, Pfizer Company but I didn't find mi real concern. I have my 2do Pfizer vaccine.  I had a light fever, malaise. (That is ok)  But I never found: I breathe but I feel like my lungs are not filling with air. Like I'm short of breath I have good oxygenation because I have an oximeter at home. (From 95 to 99%) But the lack of breath made me tired and really worry me  PS: my Doctor, who was vaccinated with modern (2 months ago) also had that shortness of breath  That was for 4 days. Today is the day #9 and still shorter in breath a litle
Vasovagal syncope reaction  Sweating nausea diarrhea paleness blurred vision ringing in ears etc
Case number PHEH2014US0255150, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 68 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 21 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
01/12/2021: Severe muscle pain in arm with injection, nausea and fatigue started at 5:30 pm 01/13/2021: All AM and PM: Extreme cold, could not warm up; nausea, fatigue, severe arm pain 01/14/2021: PM: headache, nausea, diarrhea, mild arm pain, body very cold, face very hot 01/15/2021: All AM and PM: diarrhea, nausea
Information has been received from a registered nurse concerning a 7 year old female who in September 1997, at another physician's office was vaccinated " a little early" with a dose of varicella virus vaccine live. On 01DEC2003 it was reported that the patient "recently" developed 20-25 varicella breakthrough lesions. It was unknown if medical attention was sought. it was also noted that the school district had an outbreak of "wild virus of varicella" and that no testing was done. No product complaint was involved. It was also reported that the patient's female cousin and male cousin were vaccinated with a dose of varicella virus vaccine and also developed varicella  breakthrough lesions. The nurse also reported that she did not keep these charts separate and was unable to answer the questions asked. No further information is expected.
Engerix-B third dose received on 05May2023; Expired Product Used; Inappropriate Schedule of Vaccine/had a dose documented on 05Jun2020 and 16Nov2020; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a 6-month-old male patient who received HBV (Engerix B) (batch number K329E, expiry date 24-APR-2023) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis.   Previously administered products included Engerix-B (received first dose on 5th June 2020).   On 05-MAY-2023, the patient received the 3rd dose of Engerix B. On 16-NOV-2020, the patient received the 2nd dose of Engerix B. On 11-NOV-2020, an unknown time after receiving Engerix B, the patient experienced drug dose administration interval too long (Verbatim: Inappropriate Schedule of Vaccine/had a dose documented on 05Jun2020 and 16Nov2020). On 05-MAY-2023, the patient experienced drug dose administration interval too long (Verbatim: Engerix-B third dose received on 05May2023) and expired drug used (Verbatim: Expired Product Used). The outcome of the drug dose administration interval too long, drug dose administration interval too long and expired drug used were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 09-MAY-2023 The patient was currently 3 years old. The reporter believed that this was patients' third dose in the series. The patient had no record of a third dose. At the time of reporting, expired dose had not been repeated. The vaccine administration facility was the same as primary reporter.  The reporter consented to follow up but requested no patient information via email.  The patient received 2nd and 3rd dose of Engerix-B later than the recommended schedule and 3rd dose was administered after expiration date, which led to lengthening of vaccination schedule and expired vaccine used.
Incorrect dose was administered. 0.5 ml was administered.  Correct dose is 0.25 ml.
9DEC96 student fainted p/vax hit forehead-LOC-incontinent of urine;2x1cm hematoma;
Tingling getting worse and more often; Tingling getting worse and more often; Tough time sleeping; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling getting worse and more often), CONDITION AGGRAVATED (Tingling getting worse and more often) and INSOMNIA (Tough time sleeping) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling getting worse and more often), CONDITION AGGRAVATED (Tingling getting worse and more often) and INSOMNIA (Tough time sleeping). At the time of the report, PARAESTHESIA (Tingling getting worse and more often), CONDITION AGGRAVATED (Tingling getting worse and more often) and INSOMNIA (Tough time sleeping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
A physician reported the occurrence of an injection site reaction in a 5-year-old female who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix). The pt had no known allergies or other medical history or concurrent medications. The pt experienced no adverse events following previous immunizations. On 07/31/2002 the pt received her 5th injectino of Infanrix (lot DTPA548A2) into the right leg. On the same day the pt received injections of inactivated poliomyelitis virus vaccine (IPOL, Aventis Pasteur) and measles, mumps and rubella virus vaccine (MMR II, Merck). One day later the pt developed an injection site reaction characterized by a 4-inch by 4-inch area of red rash, warmth and hardness at the Infanrix injection site. The pt was treated with diphenhydramine (Benadryl). The reporter considered the injection site reaction to be probably related to Infanrix administration. Comment: This report has been linked to reports A0376897A and A0376898A due to same reporter.
I have been diagnosed with Shingles since having had my COVID-19 vaccine. I noticed this rash that was red and splotchy and tender to the touch. It was on my right hip it then began to get more painful, it was burning, and itchy. It was bothering me enough that I was not sleeping. At first, I thought it may be a bug bite but as it spread and got worse, I reached out to my doctor and went in, and she confirmed what I had found with research and that it was shingles. They gave me an antiviral and some gabapentin to help with the nerve pain since shingles affects the nerves. I have been using calamine lotion which helps but it is still itchy and bothering me. I did have my flu vaccine the same day that I had my COVID-19 shot but I do not have the information on that shot, I also had never had a flu shot prior that day.
This spontaneous report as received via social media from an unspecified reporter, who obtained the information from the articles published on a web page, refers to many female patients of unknown age. The patients' concurrent conditions and medical history were not reported. On unknown dates, the patients were vaccinated with unknown doses of GARDASIL (lot #, expiry date, route and site of administration were not reported). Concomitant medications were not reported. On unknown dates, many of patients experienced disability. The outcome of the event was unknown. The reporter considered the event to be related to GARDASIL (it was reported that vaccine "disabled many women"). This is one of two reports received from the same reporter. Additional information has been requested.
Chronological History  1/6/21 Moderna Vaccine #1  2/3/21 Moderna Vaccine #2  2/4/21 Severe headache (continued for several days)  @ 2/15/21 Woke up with unusual sinus drainage and when I spit out there was blood in the mucus ? not just a drop or two but a lot of blood ? some looked older and some fresh. 3/4,7,14/21 Same as 2/15 ? Blood in the early morning mucus. 3/28/21 Woke up with nose bleed  4/11/21 Early morning severe top-of-head headache  4/11/21 Blood Pressure Readings: 1 pm 159/99, 3pm 154/98, 7:30pm 125/76, Midnight 123/78. Other BP Readings: ? 4/18 (Sun: 1p) 148/91 70  ? 4/17 (Sat: 2p) 133/87 71   ? 4/16 (Fri) Noon: 116/71 ? 4/13 (Tue) Noon: 133.83; 4:30p 139/87 69 ? 4/12 (Mon: 10a) 134/84:  5/4/21 Cataract Surgery ? Initial pre- and post-op meds: Ofloxacin, Lotemax and Prolensa. 5/13 & 27/21 Cataract Surgery Follow-Ups ? unable to 'laser' the extra film due to eye problems ? Treatment: Added Combigan  6/13/21 Called Ophthalmologist re: "red eyes" ? was told to use an OTC such as Systane  6/25/21 Ophthalmologist ? Possible Allergic Reaction to the Combigan he prescribed post-op ? treatment: discontinue Combigan and go back to using Lotomax 7/1, 14 & 28/2021 Ophthalmologist ? Follow-ups ? Diagnosis: Red is on the surface and not in the eye; still believes we are dealing with an allergic reaction to Combigan and possible allergic reaction to Lotomax. Treatment ? discontinue Lotomax, prescribed Alrest and an OTC non-preservative Systane.  8/18/21 Ophthalmologist ? Infection is worsening ? discontinue all eye meds (except Systane as needed) ? he recommends we get a second opinion ? provides referral to another Ophthalmologist  8/22/21 About 4pm noticed face had turned a bright red; BP: 4p 150/93; 5:15p 147/91; 6:15p: 140/90; 8:50p:155/97 8/23/21   BP: 8am: 131/90 8/24/21 BP: 10am: 143/89  Other medications: Lotomax & Pravastatin ? 1x Daily  Conclusions  Since Feb 3rd (Moderna Immunization #2), I have experienced symptoms never previously experienced.    The eyes reddening started in June while on a trip and has continued since onset.  Thus, environmental allergies, while still possible, do not seem to be either catalyst or underlying cause.    Although there may be several Differential Diagnoses and the Symptomology may allow for other conclusions, it would seem (   ) to not consider one such diagnosis to be a reaction to the Moderna vaccine.    I would appreciate your evaluation.  How do we proceed from here?
Pt recvd vax & site of inject was itchy & red; pt's arm swelled 2+ edema down to hand & eye became puffy; treated w/DPh;
Three teenagers / received an adult dose / instead of a Pediatric dose; Three teenagers / received an adult dose / instead of a Pediatric dose; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 13-year-old female patient who received HAV (Havrix adult) (batch number K4Y4L, expiry date 17th June 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 2nd June 2021, the patient received the 1st dose of Havrix adult and Havrix Pre-Filled Syringe Device. On 2nd June 2021, unknown after receiving Havrix adult and Havrix Pre-Filled Syringe Device, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient received an adult dose of Havrix instead of a Pediatric dose, which led to overdose and adult product administered to child. The reporter consented to follow up. This is 1 of the 3 cases reported by the same reporter for different patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021130437:Same reporter. Patient #2 of 3. US-GLAXOSMITHKLINE-US2021130439:Same reporter. Patient #3 of 3.
C/O soreness and swelling at immunization site. Afebrile.  Area is not warm to touch.
Systemic: Ability to hear is affected, sounds like under water or muffled-Mild, Additional Details: Patient did not receive the first vaccine here, and I did not have all the information.
This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (had a hard time sleeping), PAIN (pain subsided), VACCINATION SITE PAIN (left arm started to get sore) and MYALGIA (left arm was still sore) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and METOPROLOL for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 06-Mar-2021, the patient experienced INSOMNIA (had a hard time sleeping) and VACCINATION SITE PAIN (left arm started to get sore). On 07-Mar-2021, the patient experienced PAIN (pain subsided) and MYALGIA (left arm was still sore). The patient was treated with PARACETAMOL (TYLENOL) (oral) on 06-Mar-2021 at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) on 07-Mar-2021 at an unspecified dose and frequency. On 07-Mar-2021, VACCINATION SITE PAIN (left arm started to get sore) outcome was unknown. At the time of the report, INSOMNIA (had a hard time sleeping), PAIN (pain subsided) and MYALGIA (left arm was still sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       To reduce the soreness in arm patient used ice .   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: follow up received on 23-JUN-2021 contains no new information
Patient received a 3rd dose of Moderna Covid-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXTRA DOSE ADMINISTERED (Patient received a 3rd dose of Moderna Covid-19 vaccine) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-May-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced EXTRA DOSE ADMINISTERED (Patient received a 3rd dose of Moderna Covid-19 vaccine). On 21-May-2021, EXTRA DOSE ADMINISTERED (Patient received a 3rd dose of Moderna Covid-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
patient fainted after about 5 to 10 minutes. when I found the patient, she was already standing and talking. she looked pale and shaky. her blood pressure at the time was 97/75 with pulse 75 and oxygen at 98. about 15 to 20 minutes later, her blood pressure was 96/65 and pulse 70 and oxygen 99. she was no longer pale and her color looked like before she was given the shot. she has no other symptoms. she said she feels normal again with no difficulty breathing or any heart symptoms. patient was advised to see a doctor and she had a friend take her home.
Second dose: Pain in left side of neck and chest pain on the left side. Pain started within the hour from the time of shot. It has now been 6 hours of chest pain on the left side and not letting up. Have not noticed any other symptoms such as shortness of breath or irregular heart beat.
Debilitating pain left shoulder and neck, radiating to arm and hand, palsy of left hand saw several neurologists and eventually was diagnosed with Parsonage Turner Syndrome prescribed PT and OT. Left hand palsy and chronic pain remain.